Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post‐marketing surveillance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post‐marketing surveillance

Published:2022-05-23 Issue:9 Volume:49 Page:862-871
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:The Journal of Dermatology

Author:

Uhara Hisashi¹^ORCID,Tsuchida Tetsuya²,Kiyohara Yoshio³,Akamatsu Ayumi⁴,Sakamoto Takahiko⁴,Yamazaki Naoya⁵^ORCID

Affiliation:

1. Department of Dermatology Sapporo Medical University School of Medicine Sapporo Japan

2. Department of Dermatology Saitama Medical University Saitama Japan

3. Dermatology Division Shizuoka Cancer Center Hospital Shizuoka Japan

4. Pharmacovigilance Division Ono Pharmaceutical Osaka Japan

5. Department of Dermatologic Oncology National Cancer Center Hospital Tokyo Japan

Funder

Ono Pharmaceutical

Bristol-Myers Squibb

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.16432

Reference23 articles.

1. Characteristics of melanoma in Japan: a nationwide registry analysis 2011–2013

2. Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma

3. Epidemiological trends in the diagnosis of melanoma in a Southern European population: analysis of a large database from a tertiary referral center

4. Considering adjuvant therapy for stage II melanoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance study;Japanese Journal of Clinical Oncology;2024-09-03

2. Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan;International Journal of Clinical Oncology;2024-06-06

3. Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan;International Journal of Hematology;2024-03-23

4. Two autopsied gastric cancer cases of rare drug-induced pneumonia associated with nivolumab plus S-1 and oxaliplatin: a case report;Journal of Gastrointestinal Oncology;2024-02

5. Clinical Management of Gastrointestinal and Liver Toxicities of Immune Checkpoint Inhibitors;Clinical Colorectal Cancer;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3